ID Source | ID |
---|---|
PubMed CID | 5492607 |
MeSH ID | M0168059 |
Synonym |
---|
kri-1314 |
kri 1314 |
propan-2-yl 4-cyclohexyl-2-hydroxy-3-[[(2s)-3-(1h-imidazol-5-yl)-2-[[(2r)-4-morpholin-4-yl-2-(naphthalen-1-ylmethyl)-4-oxobutanoyl]amino]propanoyl]amino]butanoate |
cyclohexanebutanoic acid, alpha-hydroxy-beta-((3-(1h-imidazol-4-yl)-2-((4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl)amino)-1-oxopropyl)amino)-, 1-methylethyl ester |
isopropyl 3-(n-(2-(1-naphthylmethyl)-3-(morpholinocarbonyl)propionyl)-l-histidyl)amino-4-cyclohexyl-2-hydroxybutyrate |
isopropyl 3-(((n-(3-morpholinocarbonyl)-2-(1-naphthylmethyl)propionyl)histidyl)amino)-4-cyclohexyl-2-hydroxybutyrate |
128053-53-2 |
n-[1-({1-cyclohexyl-3-hydroxy-4-oxo-4-[(propan-2-yl)oxy]butan-2-yl}imino)-1-hydroxy-3-(1h-imidazol-5-yl)propan-2-yl]-4-(morpholin-4-yl)-2-[(naphthalen-1-yl)methyl]-4-oxobutanimidic acid |
DTXSID60924076 |
122089-24-1 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.05) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |